Resonetics® Expands Nitinol Manufacturing with Key Acquisition from Medical Component Specialists

Resonetics® Strengthens Nitinol Manufacturing with Strategic Acquisition

In a significant move to bolster its manufacturing capabilities, Resonetics® announced the acquisition of the nitinol gun drilling operations from Medical Component Specialists (MCS). This transaction, which took place at MCS’s facility in New Boston, New Hampshire, is a crucial step in Resonetics’ broader strategy to enhance its U.S.-based nitinol supply chain and improve material availability for innovative medical devices.

What is Nitinol?

Nitinol, a nickel-titanium alloy, is renowned for its unique properties, particularly its superelasticity and shape-memory capabilities. These characteristics make nitinol an ideal material for a variety of medical devices, including stents and guidewires, which require precise engineering and reliability in critical applications.

The Importance of Gun Drilling

The acquisition focuses on gun drilling, a specialized machining technique used to create a precision hole along the length of a bar. This process is foundational in producing high-performance nitinol tubing essential for medical devices. By incorporating MCS’s advanced gun drilling capabilities, Resonetics is positioned to significantly enhance the quality and efficiency of its nitinol products.

Kevin Kelly, the CEO of Resonetics, emphasized the acquisition's importance by stating, "Nitinol gun drilling is critical to our premium tubing initiative and our ability to improve material availability and reduce lead times for our customers." This investment not only aims at increasing supply chain resilience but also enables Resonetics to maintain its position as a leader in the nitinol industry.

Recent Investments

This acquisition follows a series of strategic investments made by Resonetics in recent years, highlighting their commitment to growth and innovation. Earlier expansions included increasing melt capacity and enhancing raw material stock, all aimed at reducing supply chain risks that could affect lead times and production efficiency.

Furthermore, Resonetics previously expanded its nitinol tubing capabilities in Bethel, Connecticut, with the acquisition of former Memry Corp. and SAES Smart Materials. This expansion has allowed Resonetics to create one of the most advanced nitinol portfolios in the industry, ensuring they can support the increasing demand for specialized medical device manufacturing.

Commitment to Customers and Innovation

As Resonetics continues to expand its capabilities, the company remains dedicated to being an open-source supplier to both original equipment manufacturers (OEMs) in the medical device sector and contract manufacturers. Kelly expressed this commitment, stating, "We welcome partnerships with customers of all sizes, and we're focused on delivering the quality, responsiveness, and innovation that accelerates medical device breakthroughs."

In summary, Resonetics' acquisition of MCS's nitinol gun drilling assets marks a strategic milestone in its mission to innovate within the medical device industry. By enhancing their production capabilities and ensuring a reliable supply of vital materials, Resonetics is poised to continue delivering exceptional quality and innovation for its clients. As healthcare continues to become more advanced, companies like Resonetics play a critical role in supporting the technology that saves lives.

About Resonetics

Founded in 1987, Resonetics is a significant player in the advanced engineering and manufacturing solutions sector for medical devices. Notable for their laser processing and nitinol manufacturing techniques, they are ISO 13485:2016 certified and operate multiple facilities across North America and Europe. With a strong emphasis on innovation and quality, Resonetics is committed to improving healthcare technologies through cutting-edge manufacturing solutions.